A potent risk model for predicting new-onset acute coronary syndrome in patients with type 2 diabetes mellitus in Northwest China

被引:23
|
作者
Lyu, Jun [1 ]
Li, Zhiying [2 ]
Wei, Huiyi [3 ]
Liu, Dandan [2 ]
Chi, Xiaoxian [2 ]
Gong, Da-Wei [4 ]
Zhao, Qingbin [2 ]
机构
[1] Xi An Jiao Tong Univ, Affiliated Hosp 1, Clin Res Ctr, Xian 710061, Shaanxi, Peoples R China
[2] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Geratol, Xian 710061, Shaanxi, Peoples R China
[3] Xi An Jiao Tong Univ, Affiliated Middle Sch 2, Xian 710061, Shaanxi, Peoples R China
[4] Univ Maryland, Sch Med, Dept Med, Div Endocrinol Diabet & Nutr, Baltimore, MD 21201 USA
基金
中国国家自然科学基金;
关键词
Cardiovascular disease; Type 2 diabetes mellitus; Risk predictive model; Northwest China; CARDIOVASCULAR-DISEASE; BLOOD-PRESSURE; MYOCARDIAL-INFARCTION; FAMILIAL HYPERCHOLESTEROLEMIA; ELEVATED LIPOPROTEIN(A); VASCULAR COMPLICATIONS; GLUCOSE CONTROL; MORTALITY; HYPERURICEMIA; ATHEROSCLEROSIS;
D O I
10.1007/s00592-020-01484-x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims Type 2 diabetes mellitus (T2DM) is now very prevalent in China. Due to the lower rate of controlled diabetes in China compared to that in developed countries, there is a higher incidence of serious cardiovascular complications, especially acute coronary syndrome (ACS). The aim of this study was to establish a potent risk predictive model in the economically disadvantaged northwest region of China, which could predict the probability of new-onset ACS in patients with T2DM. Methods Of 456 patients with T2DM admitted to the First Affiliated Hospital of Xi'an Jiaotong University from January 2018 to January 2019 and included in this study, 270 had no ACS, while 186 had newly diagnosed ACS. Overall, 32 demographic characteristics and serum biomarkers of the study patients were analysed. The least absolute shrinkage and selection operator regression was used to select variables, while the multivariate logistic regression was used to establish the predictive model that was presented using a nomogram. The area under the receiver operating characteristics curve (AUC) was used to evaluate the discriminatory capacity of the model. A calibration plot and Hosmer-Lemeshow test were used for the calibration of the predictive model, while the decision curve analysis (DCA) was used to evaluate its clinical validity. Results After random sampling, 319 and 137 T2DM patients were included in the training and validation sets, respectively. The predictive model included age, body mass index, diabetes duration, systolic blood pressure (SBP), diastolic blood pressure (DBP), low-density lipoprotein cholesterol, serum uric acid, lipoprotein(a), hypertension history and alcohol drinking status as predictors. The AUC of the predictive model and that of the internal validation set was 0.830 [95% confidence interval (CI) 0.786-0.874] and 0.827 (95% CI 0.756-0.899), respectively. The predictive model showed very good fitting degree, and DCA demonstrated a clinically effective predictive model. Conclusions A potent risk predictive model was established, which is of great value for the secondary prevention of diabetes. Weight loss, lowering of SBP and blood uric acid levels and appropriate control for DBP may significantly reduce the risk of new-onset ACS in T2DM patients in Northwest China.
引用
收藏
页码:705 / 713
页数:9
相关论文
共 50 条
  • [21] Circulating Ceramide: A New Cardiometabolic Biomarker in Patients With Comorbid Acute Coronary Syndrome and Type 2 Diabetes Mellitus
    Cao, Ruihua
    Fang, Zhiyi
    Li, Sulei
    Xu, Mengqi
    Zhang, Jibin
    Han, Dong
    Hu, Wenchao
    Yan, Liqiu
    Wang, Yabin
    Fan, Li
    Cao, Feng
    FRONTIERS IN PHYSIOLOGY, 2020, 11
  • [22] A risk scoring system to predict the risk of new-onset hypertension among patients with type 2 diabetes
    Lin, Cheng-Chieh
    Li, Chia-Ing
    Liu, Chiu-Shong
    Lin, Chih-Hsueh
    Wang, Mu-Cyun
    Yang, Shing-Yu
    Li, Tsai-Chung
    JOURNAL OF CLINICAL HYPERTENSION, 2021, 23 (08) : 1570 - 1580
  • [23] Development and Validation of Risk Prediction Model for New-Onset Diabetes After Percutaneous Coronary Intervention (NODAP): A Study Protocol for a Retrospective, Multicenter Analysis
    Li, Yiwen
    Cui, Jing
    Liu, Yanfei
    Chen, Keji
    Huang, Luqi
    Liu, Yue
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2021, 8
  • [24] Efficacy and safety of dalcetrapib in type 2 diabetes mellitus and/or metabolic syndrome patients, at high cardiovascular disease risk
    Stalenhoef, A. F. H.
    Davidson, M. H.
    Robinson, J. G.
    Burgess, T.
    Duttlinger-Maddux, R.
    Kallend, D.
    Goldberg, A. C.
    Bays, H.
    DIABETES OBESITY & METABOLISM, 2012, 14 (01) : 30 - 39
  • [25] Predicting New Onset Diabetes Mellitus in Older Taiwanese: Metabolic Syndrome or Impaired Fasting Glucose?
    Chen, Liang-Kung
    Peng, Li-Ning
    Lin, Ming-Hsien
    Lai, Hsiu-Yun
    Hwang, Shinn-Jang
    Chiou, Shu-Ti
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2009, 16 (05) : 627 - 632
  • [26] Association Between New-Onset Type 2 Diabetes and Cardiac Conduction Diseases: A Prospective Cohort Study
    Zhao, Maoxiang
    Gao, Jingli
    Chen, Shuohua
    Yao, Siyu
    Wang, Miao
    Wang, Chi
    Zhang, Sijin
    Feng, Zekun
    Tian, Lu
    Li, Yanjie
    Liu, Yang
    Wu, Shouling
    Xue, Hao
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2023, 12 (24):
  • [27] The association of inflammatory markers and periodontal indexes with the risk of coronary heart disease in Chinese patients with type 2 diabetes mellitus
    Chen, Ling
    Wei, Bin
    Xu, Liang
    Wu, Yun
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2018, 135 : 37 - 44
  • [28] International guideline comparison of lifestyle management for acute coronary syndrome and type 2 diabetes mellitus: A rapid review
    Kemp, Bridie J.
    Thompson, David R.
    Coates, Vivien
    Bond, Sarah
    Ski, Chantal F.
    Monaghan, Monica
    McGuigan, Karen
    HEALTH POLICY, 2024, 146
  • [29] Increased long-term risk of new-onset diabetes mellitus in white-coat and masked hypertension
    Mancia, Giuseppe
    Bombelli, Michele
    Facchetti, Rita
    Madotto, Fabiana
    Quarti-Trevano, Fosca
    Grassi, Guido
    Sega, Roberto
    JOURNAL OF HYPERTENSION, 2009, 27 (08) : 1672 - 1678
  • [30] Elevated remnant cholesterol increase 6-year type 2 diabetes mellitus onset risk
    Yuan, Lijun
    Liu, Jiong
    Huang, Zelin
    Zhao, Yang
    Feng, Yifei
    Yang, Xingjin
    Hu, Huifang
    Zhang, Jinli
    Li, Tianze
    Li, Yang
    Wu, Yuying
    Li, Xi
    Huang, Hao
    Hu, Fulan
    Hu, Dongsheng
    Zhang, Ming
    CLINICA CHIMICA ACTA, 2023, 541